Cash Flow Medexus Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-3.00
2.00
0.00
-6.00
-4.00
-41.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
6.00
8.00
3.00
-20.00
5.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
23.00
27.00
19.00
-7.00
-5.00
1.00
Cash Flow from Investing Activities
-24.00
-8.00
-4.00
-2.00
-10.00
-15.00
Cash Flow from Financing Activities
-23.00
7.00
-25.00
14.00
4.00
29.00
Net Cash Inflow / Outflow
-24.00
26.00
-10.00
4.00
-10.00
17.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CAD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medexus Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(CAD)
Change(%)
Profit Before Tax
-3.14288662009118
-16.610019
13.00
81.08%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
6.82893702281026
10.128398
-4.00
-32.58%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
23.2150688468213
0.385563000000001
23.00
5921.08%
Cash Flow from Investing Activities
-24.0526191070567
0
-24.00
0.00%
Cash Flow from Financing Activities
-23.2800273653544
1.748816
-24.00
-1431.19%
Net Cash Inflow / Outflow
-24.1175776255898
2.134379
-26.00
-1229.96%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -15.55% vs 40.91% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
23.22
27.49
-15.55%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
